πŸ‡ΊπŸ‡Έ FDA
Patent

US 10196384

Deuterated CFTR modulators

granted A61PA61P11/00

Quick answer

US patent 10196384 (Deuterated CFTR modulators) held by Vertex Pharmaceuticals (Europe) Limited expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals (Europe) Limited
Grant date
Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61P, A61P11/00